Saratov JOURNAL of Medical and Scientific Research

Retrocervical endometriosis: etiology, pathogenesis, classification, diagnosis and treatment

Year: 2016, volume 12 Issue: №2 Pages: 138-144
Heading: Obstetrics and Gynecology Article type: Review
Authors: Tarlamazian A.V., Stolyarova U.V.
Organization: Saratov State Medical University

The review deals with contemporary issues of etiology, pathogenesis, classification, diagnosis and treatment of retrocervical endometriosis on the basis of existing data in the literature on this disease. Among the various forms of endometrial disease incidence retrocervical endometriosis, according to various authors, is 30-34%. The process is characterized by the formation of deep infiltrative lesions, originating from the recto-vaginal septum, without capsules and clear boundaries, extensively localizing, affecting the adjacent organs with the formation of scar-adhesions and characterizing this pathology as a multi-disciplinary (gynecological, surgical, urological). There are many options etio-pathogenesis of retrocervical endometriosis, but none of them fully explains the diversity of forms of expression and localization of this pathology. Particular attention is paid to the influence of immune and hormonal factors on the development of the disease. It is noted that currently there is no single universally accepted by clinicians and morphology full classification of retrocervical endometriosis, and there are no generally accepted standards of its diagnosis. The variants of the treatment of this disease have been considered including hormonal and immunomodulatory therapies.

1. Endometriosis. In: Gynecology. 4th ed. Moscow: Geotar-Media, 2012; p. 191-208
2. Damarov M.M., Oleynikova O.N., Mayrova O.V. Genital Endometriosis opinion of the medical practitioner. Moscow: BINOM, 2013; 152 p.
3. Yarmolinskaya M.l., Tarasova M.A., Sal'kov S.A., et al. External genital endometriosis: a guide for physicians. St. Petersburg, 2010; 84 p.
4. Endometriosis: diagnosis, treatment and rehabilitation: Federal guidelines for the management of patients. Moscow, 2013; 86 p.
5. Endometriod disease. In: Gynecology. 2nd ed. St. Petersburg: SpetsLit, 2013. p. 121-133
6. Gorshkova O.N., Kogan Е.А., Chuprynin V.D. Current concepts of the pathogenesis of deep infiltrative endometriosis. Obstetrics and Gynecology 2014; (7): 14-22
7. Burlev V.A., Shorokhova M.A., Samoylova T.E. Modern principles of pathogenetic treatment of endometriosis. Consilium Medicum 2008; 2 (12): 16-19
8. Yarmolinskaya M.l. Genital endometriosis: effects of hormonal, immunological and genetic factors on the development of the course and the choice of therapy: DSc abstract. St. Petersburg, 2009; 408 p.
9. Solodovnikova N.G., Niaury D.A. The role of immune system factors in the pathogenesis of external genital endometriosis. Byulleten' federal'nogo tsentra serdtsa, krovi i endokrinologii im. Almazova V.A. 2011; (dec): 23-27
10. Unanyan A.L. Endometriosis and Female Reproductive Health. Obstetrics, Gynecology and Reproduction 2010; 4 (3): 6-11
11. Kachalina T.S, Semerikova M.V., Strongin L.G. Modern ideas of the pathogenesis of external genital endometriosis. Modern Technologies in Medicine 2011; 1: 117-122
12. Levakov S.A, Khamoshina M.B. Endometriosis: A Global breakthrough in medical treatment. Moscow: StatusPraesens, 2012; 16 p.
13. Stolyarova U.V, Khvorostukhina N.F., Tarlamazyan A.V. Principles endometriosis treatment depending on the clinical, hormonal and morphological tests. Fundamental Research 2014; 7 (3): 570-574
14. Linde V.A., Tatarova N.A. Endometriosis. Moscow: Geotar-Media, 2010; 192 p.
15. Popov А.А., Ramazanov M.R., Manannikova T.N., et al. Surgical policy for infiltrative forms of endometriosis at reproductive age. RossiTskiT vestnik akushera-ginekologa 2011; (4): 63-66
16. Marchenko L.A., H'ina L.M. Endometriosis (modern view of the pathogenesis and prospects of drug therapy). RMJ 2010; 18 (4): 171-175
17. Johnson Neil Р., Hummelshoj L. Consensus on current management of endometriosis. Reproductive Endocrinology 2013; 4 (12): 66-88
18. Shestakova IG, Ipastova ID. Endometriosis: a new consensus — new solutions: Global consensus on the management of patients with endometriosis as a first step towards the creation of industry standards: News bulletin. Moscow: StatusPraesens, 2014; 16 p.
19. Popov А.А., Ramazanov M.R., Machanskite O.V., et al. Infiltrative endometriosis — reproductive forecasts. Reproductive Medicine 2010; 3-4 (04-05): 38-41
20. Tarlamazian A.V., Stolyarova U.V., Neyfeld I.V. The problem diagnostics of the retrocervical endometriosis. Science almanac 2015; 7 (9): 917-921
21. Marchenko L.A. The advantages of treating endometriosis using a continuous mode of oral contraceptives. Consilium Medicum 2008; 2 (12): 20-25
22. Pabona JM, Simmen FA, Nikiforov M.A., et al. Kuppellike factor 9 and progesterone receptor coregulation of decidualizing endometrial stromal cells: implications for the pathogenesis of endometriosis. Clin Endocrinol Metab 2012; 97: 376-392
23. New issuies of endometriosis pathogenesis and treatment. In: New technologies for diagnosis and treatment of gynecologic diseases. Moscow: Medi Expo, 2010; p. 150-168
24. Adamson GD. Endometriosis classification: an update. CurrOpin Obstet Gynecol 2011; 23: 213-220
25. Pavlov R.V., Kundokhova M.S. Immunological Criteria for Early Prediction of External Endometriosis Recurrence. Medical News of North Caucasus 2011; 1: 39-41
26. Ve гее Mini Р, Somigliana Е, Vigano Р, et al. The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review. Acta Obstet Gynecol Scand 2009; 88: 1074-1082
27. Guzick DS, Huang LS, Broadman BA, et al. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril 2011; 95: 1568-1573
28. Vercellini P, Crosignani P, Somigliana E, et al. Waiting for Godot: a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011; 26: 3-13
29. Ferrero S, Gillott DJ, Venturini PL, et al. Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review. Reprod Biol Endocrinol 2011; 9: 89
30. Stratton P, Sinaii N, Segars J, et al. Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial. Obstet Gynecol 2008; 111: 88-96
31. Laschke MW, Menger MD Anti-angiogenetic treatment strategies for the therapy of endometriosis. Hum Reprod Update 2012; 18: 682-702.

2016_02_138-144.pdf271.22 KB

No votes yet